CN102283342B - 航天用功能性全营养流食及其制备方法 - Google Patents
航天用功能性全营养流食及其制备方法 Download PDFInfo
- Publication number
- CN102283342B CN102283342B CN 201110178050 CN201110178050A CN102283342B CN 102283342 B CN102283342 B CN 102283342B CN 201110178050 CN201110178050 CN 201110178050 CN 201110178050 A CN201110178050 A CN 201110178050A CN 102283342 B CN102283342 B CN 102283342B
- Authority
- CN
- China
- Prior art keywords
- liquid food
- group
- nutrition liquid
- full nutrition
- functional full
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000021056 liquid food Nutrition 0.000 title claims abstract description 86
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 244000068988 Glycine max Species 0.000 claims abstract description 16
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 16
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 15
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 11
- 239000003792 electrolyte Substances 0.000 claims abstract description 9
- 239000000839 emulsion Substances 0.000 claims abstract description 9
- 239000003381 stabilizer Substances 0.000 claims abstract description 9
- 229940088594 vitamin Drugs 0.000 claims abstract description 9
- 229930003231 vitamin Natural products 0.000 claims abstract description 9
- 235000013343 vitamin Nutrition 0.000 claims abstract description 9
- 239000011782 vitamin Substances 0.000 claims abstract description 9
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 8
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 8
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 8
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 8
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 8
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 8
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 8
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 8
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 8
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 8
- 235000002722 Dioscorea batatas Nutrition 0.000 claims abstract description 8
- 235000006536 Dioscorea esculenta Nutrition 0.000 claims abstract description 8
- 240000001811 Dioscorea oppositifolia Species 0.000 claims abstract description 8
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 claims abstract description 8
- 108010010803 Gelatin Proteins 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 229920000159 gelatin Polymers 0.000 claims abstract description 8
- 239000008273 gelatin Substances 0.000 claims abstract description 8
- 235000019322 gelatine Nutrition 0.000 claims abstract description 8
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 8
- 150000002632 lipids Chemical class 0.000 claims abstract description 8
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 8
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 8
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims abstract description 7
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims abstract description 7
- 235000013406 prebiotics Nutrition 0.000 claims abstract description 7
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims abstract description 7
- 240000000171 Crataegus monogyna Species 0.000 claims abstract 2
- 235000016709 nutrition Nutrition 0.000 claims description 73
- 230000035764 nutrition Effects 0.000 claims description 69
- 238000000034 method Methods 0.000 claims description 18
- 235000018102 proteins Nutrition 0.000 claims description 14
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 12
- 239000000787 lecithin Substances 0.000 claims description 11
- 229940067606 lecithin Drugs 0.000 claims description 11
- 235000010445 lecithin Nutrition 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 102000008186 Collagen Human genes 0.000 claims description 10
- 108010035532 Collagen Proteins 0.000 claims description 10
- 229920001436 collagen Polymers 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 10
- 239000010495 camellia oil Substances 0.000 claims description 9
- 235000014633 carbohydrates Nutrition 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 229920001184 polypeptide Polymers 0.000 claims description 8
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 8
- 241000756943 Codonopsis Species 0.000 claims description 7
- 239000009636 Huang Qi Substances 0.000 claims description 7
- 239000005913 Maltodextrin Substances 0.000 claims description 7
- 229920002774 Maltodextrin Polymers 0.000 claims description 7
- 244000197580 Poria cocos Species 0.000 claims description 7
- 239000005018 casein Substances 0.000 claims description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 7
- 235000021240 caseins Nutrition 0.000 claims description 7
- 229940035034 maltodextrin Drugs 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 6
- 239000011707 mineral Substances 0.000 claims description 6
- CODAYFPFZXWNLD-UHFFFAOYSA-N 2-hydroxypropanoyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(=O)C(C)O CODAYFPFZXWNLD-UHFFFAOYSA-N 0.000 claims description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 4
- 239000000084 colloidal system Substances 0.000 claims description 4
- 230000001804 emulsifying effect Effects 0.000 claims description 4
- 230000005070 ripening Effects 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 238000000227 grinding Methods 0.000 claims description 3
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 claims description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims description 2
- 150000002617 leukotrienes Chemical class 0.000 claims description 2
- 235000020778 linoleic acid Nutrition 0.000 claims description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims description 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims description 2
- 150000008104 phosphatidylethanolamines Chemical class 0.000 claims description 2
- 229940067626 phosphatidylinositols Drugs 0.000 claims description 2
- 150000003905 phosphatidylinositols Chemical class 0.000 claims description 2
- 238000009461 vacuum packaging Methods 0.000 claims description 2
- 229960002648 alanylglutamine Drugs 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 abstract description 20
- 239000011575 calcium Substances 0.000 abstract description 10
- 229910052791 calcium Inorganic materials 0.000 abstract description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 9
- 230000036737 immune function Effects 0.000 abstract description 9
- 210000000988 bone and bone Anatomy 0.000 abstract description 8
- 230000000968 intestinal effect Effects 0.000 abstract description 8
- 201000000585 muscular atrophy Diseases 0.000 abstract description 5
- 230000004206 stomach function Effects 0.000 abstract description 5
- 239000011573 trace mineral Substances 0.000 abstract description 3
- 235000013619 trace mineral Nutrition 0.000 abstract description 3
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 206010028289 Muscle atrophy Diseases 0.000 abstract 1
- 244000248825 Peltandra virginica Species 0.000 abstract 1
- 235000001188 Peltandra virginica Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 230000020763 muscle atrophy Effects 0.000 abstract 1
- 230000001228 trophic effect Effects 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 50
- 208000014674 injury Diseases 0.000 description 31
- 230000008733 trauma Effects 0.000 description 31
- 238000012360 testing method Methods 0.000 description 25
- 210000002966 serum Anatomy 0.000 description 21
- 239000000835 fiber Substances 0.000 description 20
- 206010052428 Wound Diseases 0.000 description 17
- 208000027418 Wounds and injury Diseases 0.000 description 17
- 230000000694 effects Effects 0.000 description 17
- 230000006870 function Effects 0.000 description 15
- 210000001035 gastrointestinal tract Anatomy 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 13
- 210000001541 thymus gland Anatomy 0.000 description 13
- 235000013305 food Nutrition 0.000 description 12
- 241000186000 Bifidobacterium Species 0.000 description 10
- 230000037396 body weight Effects 0.000 description 10
- 230000029663 wound healing Effects 0.000 description 10
- 241000186660 Lactobacillus Species 0.000 description 9
- 102000019197 Superoxide Dismutase Human genes 0.000 description 9
- 108010012715 Superoxide dismutase Proteins 0.000 description 9
- 239000013065 commercial product Substances 0.000 description 9
- 229940039696 lactobacillus Drugs 0.000 description 9
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 8
- 108090000978 Interleukin-4 Proteins 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 8
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 8
- 230000036039 immunity Effects 0.000 description 8
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 8
- 230000035882 stress Effects 0.000 description 8
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000003203 everyday effect Effects 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 241001092040 Crataegus Species 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 230000037182 bone density Effects 0.000 description 6
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000606125 Bacteroides Species 0.000 description 4
- 206010065687 Bone loss Diseases 0.000 description 4
- 108010016626 Dipeptides Proteins 0.000 description 4
- 102000004067 Osteocalcin Human genes 0.000 description 4
- 108090000573 Osteocalcin Proteins 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical group C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 230000007661 gastrointestinal function Effects 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000011775 sodium fluoride Substances 0.000 description 4
- 235000013024 sodium fluoride Nutrition 0.000 description 4
- 239000011781 sodium selenite Substances 0.000 description 4
- 235000015921 sodium selenite Nutrition 0.000 description 4
- 210000002303 tibia Anatomy 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- 210000000689 upper leg Anatomy 0.000 description 4
- 239000011670 zinc gluconate Substances 0.000 description 4
- 235000011478 zinc gluconate Nutrition 0.000 description 4
- 206010002091 Anaesthesia Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 3
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 3
- 241000305071 Enterobacterales Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 239000001506 calcium phosphate Substances 0.000 description 3
- 229910000389 calcium phosphate Inorganic materials 0.000 description 3
- 235000011010 calcium phosphates Nutrition 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229940108925 copper gluconate Drugs 0.000 description 3
- 230000001934 delay Effects 0.000 description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 3
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000003608 fece Anatomy 0.000 description 3
- 239000011790 ferrous sulphate Substances 0.000 description 3
- 235000003891 ferrous sulphate Nutrition 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 3
- 230000001900 immune effect Effects 0.000 description 3
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 3
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- 239000011683 manganese gluconate Substances 0.000 description 3
- 235000014012 manganese gluconate Nutrition 0.000 description 3
- 229940072543 manganese gluconate Drugs 0.000 description 3
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000001508 potassium citrate Substances 0.000 description 3
- 229960002635 potassium citrate Drugs 0.000 description 3
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 3
- 235000011082 potassium citrates Nutrition 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000011684 sodium molybdate Substances 0.000 description 3
- 235000015393 sodium molybdate Nutrition 0.000 description 3
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 3
- 229960001471 sodium selenite Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 238000004804 winding Methods 0.000 description 3
- 229960000306 zinc gluconate Drugs 0.000 description 3
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 2
- 102000006996 Aryldialkylphosphatase Human genes 0.000 description 2
- 108010008184 Aryldialkylphosphatase Proteins 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 235000019743 Choline chloride Nutrition 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 241000194033 Enterococcus Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 108010044940 alanylglutamine Proteins 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 229960003178 choline chloride Drugs 0.000 description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011772 phylloquinone Substances 0.000 description 2
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000008160 pyridoxine Nutrition 0.000 description 2
- 239000011677 pyridoxine Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 210000001694 thigh bone Anatomy 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- LLIANSAISVOLHR-GBCQHVBFSA-N 5-[(3as,4s,6ar)-2-oxidanylidene-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoic acid Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21.N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 LLIANSAISVOLHR-GBCQHVBFSA-N 0.000 description 1
- 206010070545 Bacterial translocation Diseases 0.000 description 1
- 229910021556 Chromium(III) chloride Inorganic materials 0.000 description 1
- 208000019505 Deglutition disease Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 229930182816 L-glutamine Natural products 0.000 description 1
- 241001417092 Macrouridae Species 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 229910003424 Na2SeO3 Inorganic materials 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 206010033645 Pancreatitis Diseases 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 206010049416 Short-bowel syndrome Diseases 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 235000009233 Stachytarpheta cayennensis Nutrition 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 241000256856 Vespidae Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 230000007375 bacterial translocation Effects 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000011636 chromium(III) chloride Substances 0.000 description 1
- 235000007831 chromium(III) chloride Nutrition 0.000 description 1
- 208000017580 chronic wasting disease Diseases 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000018823 dietary intake Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 229910052564 epsomite Inorganic materials 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 210000003194 forelimb Anatomy 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000002758 humerus Anatomy 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229910052603 melanterite Inorganic materials 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 229940088154 niacinamide 15 mg Drugs 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940104757 vitamin E 50 mg Drugs 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
化学名称 | 分子式 | 分子量 |
柠檬酸钠 | C6H5O7Na3·2H2O | 294.10 |
柠檬酸钾 | C6H5O7K3·H2O | 324.41 |
氯化钠 | NaCl | 58.44 |
磷酸钙 | Ca3(PO4)2 | 310 |
氯化钾 | KCl | 74.55 |
硫酸镁 | MgSO4·7H2O | 246.47 |
硫酸亚铁 | FeSO4·7H2O | 278.03 |
葡萄糖酸锌 | C12H22O14Zn | 455 |
葡萄糖酸铜 | Cu(C6H11O7)2 | 453.84 |
葡萄糖酸锰 | C12H22MnO14·2H2O | 481.27 |
碘化钾 | KI | 166.00 |
氯化铬 | CrCl3·6H2O | 266.49 |
钼酸钠 | Na2MOO4·2H2O | 241.95 |
氟化钠 | NaF | 41.99 |
亚硒酸钠 | Na2SeO3 | 172.94 |
名称 | 用量(/kg) | 名称 | 用量(/kg) |
山药 | 2g | 炒麦芽 | 4g |
党参 | 4g | 甘草 | 3g |
当归 | 3g | 茯苓 | 2g |
阿胶 | 3g | 卵磷脂 | 2g |
黄芪 | 2g | 水苏糖或大豆低聚糖 | 2g |
山楂 | 4g | 麦芽糊精 | 150g |
异麦芽酮糖 | 50g | 酪蛋白 | 25.68g |
大豆多肽 | 25.68g | 水解胶原蛋白 | 9.63g |
茶叶籽油 | 36g | 中链脂肪酸甘油酯 | 13g |
柠檬酸钠 | 2156mg | 视黄醇 | 1mg |
柠檬酸钾 | 2122mg | 维生素D3 | 5μg |
氯化钠 | 1236mg | 维生素E | 50mg |
磷酸钙 | 1850mg | 维生素K1 | 40μg |
氯化钾 | 525mg | 硫胺素(维生素B1) | 2mg |
硫酸镁 | 878mg | 核黄素(维生素B2) | 2mg |
硫酸亚铁 | 14mg | 泛酸钙 | 3mg |
葡萄糖酸锌 | 56mg | 烟酰胺 | 15mg |
葡萄糖酸铜 | 7mg | 吡哆醇(维生素B6) | 2mg |
葡萄糖酸锰 | 16mg | 钴胺素(维生素B12) | 1μg |
碘化钾 | 98μg | 维生素H(生物素) | 15μg |
氯化铬 | 94μg | 叶酸 | 200μg |
钼酸钠 | 64μg | 维生素C | 50mg |
氟化钠 | 2mg | 氯化胆碱 | 266mg |
亚硒酸钠 | 38μg | 丙谷二肽 | 3.21g |
黄原胶 | 1.0g | 硬脂酰乳酸钠 | 1.5g |
柠檬酸单甘酯 | 2.5g | 纯净水 | 用纯净水补充至1L |
名称 | 用量(/kg) | 名称 | 用量(/kg) |
山药 | 3g | 炒麦芽 | 3g |
党参 | 2g | 甘草 | 2g |
当归 | 2g | 茯苓 | 4g |
阿胶 | 2g | 卵磷脂 | 2g |
黄芪 | 4g | 水苏糖或大豆低聚糖 | 1g |
山楂 | 3g | 麦芽糊精 | 34.5g |
异麦芽酮糖 | 103.5g | 酪蛋白 | 16.8g |
大豆多肽 | 16.8g | 水解胶原蛋白 | 4.2g |
茶叶籽油 | 25g | 中链脂肪酸甘油酯 | 7g |
柠檬酸钠 | 1034mg | 视黄醇 | 0.4mg |
柠檬酸钾 | 1829mg | 维生素D3 | 5μg |
氯化钠 | 1154mg | 维生素E | 7mg |
磷酸钙 | 1779mg | 维生素K1 | 60μg |
氯化钾 | 630mg | 硫胺素(维生素B1) | 1mg |
硫酸镁 | 878mg | 核黄素(维生素B2) | 1mg |
硫酸亚铁 | 22mg | 泛酸钙 | 3mg |
葡萄糖酸锌 | 56mg | 烟酰胺 | 7mg |
葡萄糖酸铜 | 7mg | 吡哆醇(维生素B6) | 1mg |
葡萄糖酸锰 | 16mg | 钴胺素(维生素B12) | 1μg |
碘化钾 | 98μg | 维生素H(生物素) | 15μg |
氯化铬 | 94μg | 叶酸 | 200μg |
钼酸钠 | 64μg | 维生素C | 50mg |
氟化钠 | 2mg | 氯化胆碱 | 346mg |
亚硒酸钠 | 38μg | 丙谷二肽 | 4.2g |
黄原胶 | 1.5g | 硬脂酰乳酸钠 | 1g |
柠檬酸单甘酯 | 2g | 纯净水 | 用纯净水补充至1L |
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110178050 CN102283342B (zh) | 2011-06-29 | 2011-06-29 | 航天用功能性全营养流食及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110178050 CN102283342B (zh) | 2011-06-29 | 2011-06-29 | 航天用功能性全营养流食及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102283342A CN102283342A (zh) | 2011-12-21 |
CN102283342B true CN102283342B (zh) | 2013-08-14 |
Family
ID=45330321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110178050 Active CN102283342B (zh) | 2011-06-29 | 2011-06-29 | 航天用功能性全营养流食及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102283342B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103416567A (zh) * | 2013-08-28 | 2013-12-04 | 北京绿源求证科技发展有限责任公司 | 一种食疗保健减肥茶冲剂 |
CN108783420A (zh) * | 2017-05-02 | 2018-11-13 | 许昌神飞航天生物科技有限公司 | 一种用于提高航天员体质的天贝复合制剂 |
CN107279640A (zh) * | 2017-07-10 | 2017-10-24 | 广西驰胜农业科技有限公司 | 一种百香果饮料及其制备方法 |
CN109744532A (zh) * | 2017-11-01 | 2019-05-14 | 北京神飞航天应用技术研究院 | 一种适合航天员调节血脂和改善记忆力的固体饮品及其制备方法 |
CN109156714A (zh) * | 2018-09-14 | 2019-01-08 | 曾庆桂 | 一种能形成粪便并能及时促排的营养流食及其制备方法 |
CN112914099B (zh) * | 2021-02-04 | 2023-07-14 | 建昌帮药业有限公司 | 一种女性产后用抗皱组合物及其制备方法和应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1568801A (zh) * | 2003-07-11 | 2005-01-26 | 西安力邦临床营养有限公司 | 一种全营养流食的生产方法 |
CN101636091A (zh) * | 2007-01-15 | 2010-01-27 | 明治乳业株式会社 | 含有矿物成分和/或维生素成分的稀释液及固体食品 |
CN101711833A (zh) * | 2009-01-19 | 2010-05-26 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗亚健康人群疲劳综合症、艾滋病人乏力、免疫功能低下的药物组合物及其制备方法 |
CA2749401A1 (en) * | 2009-01-19 | 2010-07-22 | Nutri Co., Ltd. | Low-concentration nutritional composition |
-
2011
- 2011-06-29 CN CN 201110178050 patent/CN102283342B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1568801A (zh) * | 2003-07-11 | 2005-01-26 | 西安力邦临床营养有限公司 | 一种全营养流食的生产方法 |
CN101636091A (zh) * | 2007-01-15 | 2010-01-27 | 明治乳业株式会社 | 含有矿物成分和/或维生素成分的稀释液及固体食品 |
CN101711833A (zh) * | 2009-01-19 | 2010-05-26 | 泰一和浦(北京)中医药研究院有限公司 | 一种治疗亚健康人群疲劳综合症、艾滋病人乏力、免疫功能低下的药物组合物及其制备方法 |
CA2749401A1 (en) * | 2009-01-19 | 2010-07-22 | Nutri Co., Ltd. | Low-concentration nutritional composition |
Non-Patent Citations (4)
Title |
---|
桥诘直孝.营养补充与维生素.《日本医学介绍》.1985,第6卷(第2期),第61-62页. |
滕育英.航天食品.《中国航天》.1992,(第11期),第16-19页. |
航天食品;滕育英;《中国航天》;19921231(第11期);第16-19页 * |
营养补充与维生素;桥诘直孝;《日本医学介绍》;19851231;第6卷(第2期);第61-62页 * |
Also Published As
Publication number | Publication date |
---|---|
CN102283342A (zh) | 2011-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109329907A (zh) | 一种营养代餐粉及其制备方法 | |
CN102283342B (zh) | 航天用功能性全营养流食及其制备方法 | |
CN107319525A (zh) | 一种减肥减脂专用型临床营养配方及其制备方法 | |
CN109645320A (zh) | 一种轻断食全营养配方可冲泡即食棒及其制备方法 | |
CN108618129A (zh) | 肌肉衰减综合症专用型临床营养配方及其制备方法 | |
JP5373227B1 (ja) | 栄養組成物の製造方法 | |
CN106983151A (zh) | 一种炎性肠病专用型临床营养配方及其制备方法 | |
CN103025178B (zh) | 用于从胃肠外营养转换至肠内营养的营养组合物和方法 | |
TW200911278A (en) | Reduction of risk of diarrhoea | |
CN108244252A (zh) | 益生菌多元蛋白粉及其制备方法 | |
CN105407741A (zh) | 增强脑发育的营养组合物 | |
KR101539382B1 (ko) | 장 기능 개선 및 배변 촉진용 식품 조성물 | |
CN110643524B (zh) | 一种具有胃肠道粘膜保护作用的复合益生菌制剂及其应用 | |
CN104994748A (zh) | 含有乳铁蛋白的乳基营养组合物及其用途 | |
CN105705037A (zh) | 用于抑制肿瘤生长的营养组合物 | |
CN104855985A (zh) | 尿酸高非全营养配方食品 | |
CN108703365A (zh) | 蛋白质过敏专用型临床营养配方及其制备方法 | |
CN104872677A (zh) | 一种有助于益生菌在宿主体内定植和增殖的膳食组合物及其应用 | |
CN109730309A (zh) | 健脑益智安神缓解压力益智仁复合多肽营养素及制备方法 | |
CN107668721A (zh) | 包含乳铁蛋白的营养组合物在支持抵抗疾病和状况中的用途 | |
JP4383165B2 (ja) | 細菌過剰増殖を防止する栄養組成物 | |
CN110353046A (zh) | 一种牛奶蛋白固体饮料及其制备工艺 | |
CN104839685A (zh) | 创伤感染手术及其它应急状态医学配方食品 | |
CN104839673A (zh) | 肾衰竭医学配方食品 | |
CN104855969A (zh) | 肝病非全营养配方食品 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING GUANGCAI FEITIAN MEDIA TECHNOLOGY CO., LTD Effective date: 20140703 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20140703 Address after: 100094 Haidian District North Road, Beijing, No. 26 hospital Patentee after: SCIENTIFIC RESEARCH TRAINING CENTER FOR CHINESE ASTRONAUTS Patentee after: BEIJING GUANGCAI FLYING MEDIA TECHNOLOGY CO.,LTD. Patentee after: AVIATION FLYING (BEIJING) TECHNOLOGY CO.,LTD. Address before: 100094 Haidian District North Road, Beijing, No. 26 hospital Patentee before: SCIENTIFIC RESEARCH TRAINING CENTER FOR CHINESE ASTRONAUTS |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING GUANGCAI FEITIAN MEDIA TECHNOLOGY CO., LTD. ZHONGHANG FEITIAN (BEIJING) TECHNOLOGY CO., LTD. Effective date: 20150908 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150908 Address after: 100094 Haidian District North Road, Beijing, No. 26 hospital Patentee after: SCIENTIFIC RESEARCH TRAINING CENTER FOR CHINESE ASTRONAUTS Address before: 100094 Haidian District North Road, Beijing, No. 26 hospital Patentee before: SCIENTIFIC RESEARCH TRAINING CENTER FOR CHINESE ASTRONAUTS Patentee before: BEIJING GUANGCAI FLYING MEDIA TECHNOLOGY CO.,LTD. Patentee before: AVIATION FLYING (BEIJING) TECHNOLOGY CO.,LTD. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161226 Address after: 415000 Hunan Province Economic and Technological Development Zone Changde Qianming Road 107 Patentee after: HUNAN GONGWE SPECIAL MEDICAL FORMULA FOOD CO.,LTD. Address before: 410011 Hunan province Changsha Yingbin Road No. 238 Patentee before: HUNAN PROVINCIAL CIVIL-MILITARY INTEGRATION EQUIPMENT TECHNOLOGY INNOVATION CENTER Effective date of registration: 20161226 Address after: 410011 Hunan province Changsha Yingbin Road No. 238 Patentee after: HUNAN PROVINCIAL CIVIL-MILITARY INTEGRATION EQUIPMENT TECHNOLOGY INNOVATION CENTER Address before: 100094 Haidian District North Road, Beijing, No. 26 hospital Patentee before: SCIENTIFIC RESEARCH TRAINING CENTER FOR CHINESE ASTRONAUTS |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180608 Address after: 550000 Guizhou Province Guizhou New Area Biotechnology Industry Park Patentee after: Guizhou Tai Bang Aerospace Medicine Formula Food Co.,Ltd. Address before: 415000 Qian Ming Road, Changde economic and Technological Development Zone, Hunan 107 Patentee before: HUNAN GONGWE SPECIAL MEDICAL FORMULA FOOD CO.,LTD. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 550000 Standard Workshop of Southern Park of Guian New Area High-end Equipment Manufacturing Industrial Park, Guizhou Province Patentee after: Huarui (Gui'an New Area) Aerospace Medical Formula Food Co.,Ltd. Address before: 550000 Biotechnology Industrial Park in Guian New District, Guizhou Province Patentee before: Guizhou Tai Bang Aerospace Medicine Formula Food Co.,Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 550000 standard workshop in southern zone of high end equipment manufacturing industrial park in Gui'an New District, Guizhou Province Patentee after: Shanjian Aerospace (Gui'an New Area) Medical Formula Food Co.,Ltd. Address before: 550000 standard workshop in southern zone of high end equipment manufacturing industrial park in Gui'an New District, Guizhou Province Patentee before: Huarui (Gui'an New Area) Aerospace Medical Formula Food Co.,Ltd. |